Bio-Rad Laboratories Inc (BIO)

Pretax margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm)	US$ in thousands	-2,342,482	-1,005,190	-1,729,708	-443,858	-850,107	-187,219	-533,489	-255,939	-4,711,788	-7,841,128	-2,609,730	-230,070	5,438,150	8,554,740	5,216,970	5,306,130	4,907,629	4,528,529	2,508,853	2,032,514
Revenue (ttm)	US$ in thousands	2,566,525	2,580,209	2,562,604	2,605,238	2,671,262	2,720,366	2,769,042	2,779,031	2,802,249	2,804,730	2,870,979	2,895,811	2,922,545	2,979,615	2,879,829	2,700,778	2,545,626	2,380,215	2,293,585	2,329,324
Pretax margin		-91.27%	-38.96%	-67.50%	-17.04%	-31.82%	-6.88%	-19.27%	-9.21%	-168.14%	-279.57%	-90.90%	-7.94%	186.08%	287.11%	181.16%	196.47%	192.79%	190.26%	109.39%	87.26%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-2,342,482K ÷ $2,566,525K
= -91.27%

The pretax margin of Bio-Rad Laboratories Inc has seen significant fluctuations over the periods provided. Starting positively with a strong 87.26% in March 2020, the pretax margin increased to peak at 287.11% in September 2021. However, the margin declined sharply thereafter, dropping to -91.27% by December 2024. This negative trend suggests that the company's pre-tax earnings are insufficient to cover its operating expenses and taxes, signaling potential financial difficulties. The erratic nature of the pretax margin indicates fluctuations in the company's profitability, possibly influenced by varying revenue and cost structures during the periods analyzed.